- Home
- COCP
as 01-17-2025 4:00pm EST
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 20.1M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 93.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.33 - $3.26 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cocrystal Pharma Inc. News
COCP Breaking Stock News: Dive into COCP Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
11 days ago
COCP: Phase 2a Trial of CC-42344 Extended…
GlobeNewswire
11 days ago
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
Clinical Trials Arena
17 days ago
Cocrystal to extend enrolment in Phase IIa influenza inhibitor trial
GuruFocus.com
18 days ago
Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement
MT Newswires
18 days ago
Top Midday Decliners
MT Newswires
19 days ago
Cocrystal Pharma Extends Phase 2A Influenza Challenge Study; Shares Fall
GlobeNewswire
19 days ago
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
Simply Wall St.
a month ago
US Penny Stocks To Watch In December 2024
Compare COCP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COCP Cocrystal Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.